Claude can now help design new drugs
The company used its Claude models to design small proteins that attach to specific targets in the body. This is a vital step in creating new treatments for diseases. The AI managed the entire process on its own by guiding existing scientific tools.
Results show that these AI designs were successful up to 35 percent of the time. This is much better than the typical industry success rate of 10 to 15 percent. It suggests that AI could speed up drug discovery significantly.
Other labs can now use this same method for their own research. Experts are currently reviewing these findings to confirm the results. This approach could change how scientists develop medicine in the future.
Comments (0)
No comments yet. Be the first!
More AI news
NewsNew AI Tool Fixes Mistakes in Financial Research
Researchers developed a new framework to stop AI from learning from its own bad data in financial trading models.
NewsPerplexity adds local AI to Mac apps
The new update lets your Mac handle some AI tasks directly on your computer.
NewsMeta Releases Muse Image Model on Fal
Meta has launched a new AI model on the Fal platform that plans and edits images on its own.